International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: http://www.sciepub.com/journal/ijcd Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
Go
International Journal of Celiac Disease. 2018, 6(1), 14-19
DOI: 10.12691/ijcd-6-1-4
Open AccessArticle

The Utility of Routine Endoscopic Distal Duodenal Biopsy in Patients with Irritable Bowel Syndrome for Celiac Disease Diagnosis; First Study from Nepal

Mohan Khadka1,

1Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal

Pub. Date: April 02, 2018

Cite this paper:
Mohan Khadka. The Utility of Routine Endoscopic Distal Duodenal Biopsy in Patients with Irritable Bowel Syndrome for Celiac Disease Diagnosis; First Study from Nepal. International Journal of Celiac Disease. 2018; 6(1):14-19. doi: 10.12691/ijcd-6-1-4

Abstract

Aim: To investigate the utility of routine endoscopic distal duodenal biopsy in patients with Irritable Bowel Syndrome (IBS) for the diagnosis of Celiac Disease (CD). Method: This study was conducted at the outpatient Department of Gastroenterology at the Institute of Medicine, Tribhuvan University, Kathmandu, Nepal. One hundred patients with IBS selected by Rome III Criteria were prospectively evaluated from April 2015 through March 2016. Esophagogastroduodenoscopy (EGD) was performed on all patients, with four-quadrant distal duodenal biopsies obtained from each patient. The biopsy sections were studied for Marsh-type histology, a histology characteristic of CD. Patients with Marsh-type histology had Immunoglobulin-A anti-tissue transglutaminase (IgA anti tTG) serology ordered, were recommended to start a gluten-free diet (GFD), and were followed up in clinic in 3-6 weeks. The prevalence of CD (defined as Marsh histology grade I-III with serology positive responding to GFD) was calculated in patients with IBS as a whole and among IBS subtypes. Statistical analysis was done using SPSS version 19 software (Chicago, IL, USA). Results: Of the 100 IBS patients evaluated, 50 patients had abnormal duodenal histology. Among these 50 patients, 13 had Marsh-type histology, and the remaining 37 had non-specific duodenitis. Of the 13 patients with Marsh-type histology, 4 were seropositive for CD and 9 were seronegative. The overall prevalence of CD was 4%. All 4 seropositive and 2 out of 9 seronegative patients responded to GFD in 3 to 6 weeks. Conclusion: Routine endoscopic distal duodenal biopsy is useful for the diagnosis of CD in patients with IBS as it could also detect the disease in patients with negative celiac serology.

Keywords:
irritable bowel syndrome celiac disease HLA-DQ2/DQ8 marsh classification gluten free diet

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-9.
 
[2]  Valenzuela J, Alvarado J, Cohen H, Damiao A, Francisconi C, Frugone L, Gonzalez JC, Hernandez A et al. Latin American consensus document on irritable bowel syndrome. Gastroenterol Hepatol 2004; 27: 325-43.
 
[3]  Everhart JE and Renault PF: Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 100: 998-1005, 1991.
 
[4]  Harvey RF, Salih SY and Read AE: Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1: 632-634, 1983.
 
[5]  Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 2812-9.
 
[6]  Shahbazkhani B, Forootan M, Merat S, Akbari MR, Nasserimoghadam S, Vahedi H, Malekzadeh R. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 231-5.
 
[7]  Ramırez-Cervantes KL, Remes Troche JM, Del Pilar Milke-Garcıa M, Romero V, Uscanga LF. Characteristics and factors related to quality of life in Mexican Mestizo patients with celiac disease. BMC Gastroenterol 2015; 15:4.
 
[8]  Rostami K, Malekzadeh R, Shahbazkhani B, Akbari MR, Catassi C. Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder? Dig Liver Dis 2004; 36:694-7.
 
[9]  Corazza GR, Brusco G, Andreani ML, Biagi F, Stefano MD, Gasbarrini G. Previous misdiagnosis and diagnostic delay in adult celiac sprue. J clin Gastroenterol 1996; 22: 324-5.
 
[10]  Sanders DS, Carter MJ, Hurlstone DP, Pearce A, Ward AM, Mc Alindon ME, Lobo AJ. An association of adult celiac disease with irritable bowel syndrome: a case-control study in patients’ fulfilling ROME II criteria referred to secondary care. Lancet 2001; 358: 1504-8.
 
[11]  Locke GR III, Murray JA, Zinsmeister AR, Melton LJ III, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc 2004; 79: 476-82.
 
[12]  Agreus L, Svardsudd K, Tibblin G, Lavro B. Endomysium antibodies are superior to gliadin antibodies in screening for coeliac disease in patients presenting supposed functional gastrointestinal symptoms. Scand J Prim Health Care 2000; 18: 105-10.
 
[13]  Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV, Hadjivassiliou M, Lobo AJ. A primary care cross-sectional study of undiagnosed coeliac disease. Eur J Gastroenterol Hepatol 2003; 15: 407-13.
 
[14]  Chey WD, Nojkov B, Saad RJ, Rai J, Kim CH, Lee DH, Andrews AH, Cash BD. Screening for celiac sprue in patients with suspected irritable bowel syndrome: results from a prospective US multi-center trial. Gastroenterology 2007; 132 (Suppl. 1): A147.
 
[15]  Ozdil K, Sokmen M, Ersoy O, Demirsoy H, Kesici B, Karaca C, Akbayir N, Erdem L et al. Association of gluten enteropathy and irritable bowel syndrome in adult Turkish population. Dig Dis Sci 2008; 53: 1852-5.
 
[16]  Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel B. Utility of diagnostic tests for celiac diseases in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastro 2008 (Suppl. 1): S 463.
 
[17]  Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Int Med 2009; 169: 651-8.
 
[18]  Spiegel BMR, De Rosa VP, Gralnek IM, Wang V, Dulai GS. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost effectiveness analysis. Gastroenterology 2004; 126: 1721-32.
 
[19]  Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. American College of Gastroenterology clinical guideline: diagnosis and management of celiac disease. Am J Gastroenterol 2013; 108: 656-77.
 
[20]  Emami MH1, Kouhestani S2, Gholamrezaei A2, Hashemi M2, Mahzouni P3, Raeisi M2, Daghaghzadeh H4, Daneshgar H5: Prevalence of Celiac Disease in Patients with Irritable Bowel Syndrome. Govaresh\Vol. 13\No. 3\ Autumn 2008.
 
[21]  Richard J. Farrell and Ciarán P. Kelly: Celiac disease and refractory celiac disease. 9th edition. Sleisenger and Fordtran’s gastrointestinal and liver disease.
 
[22]  Pironti A, Tadeu V, Pedroni A, Porcu A, Manca A, Massarelli G, Realdi G, Dore MP. Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms. Minerva Med. 2010 Jun; 101(3):129-34.
 
[23]  Freeman HJ. Detection of adult celiac disease with duodenal screening biopsies over a 30-year period.Canadian J Gastroenterol. Jul 2013; 27(7): 405-408.
 
[24]  Cash BD, Rubenstein JH, Young PE, Gentry A, Nojkov B, Lee D, Andrews AH, Dobhan R et al. The prevalence of celiac disease among patients with non-constipated irritable bowel syndrome is similar to controls. Gastroenterology 2011; 141: 1187-93.
 
[25]  Choung RS, Rubio-Tapia A, Lahr BD, Kyle RA, Camilleri MJ, Locke GR 3rd, Talley NJ, Murray JA. Evidence against routine testing of patients with functional gastrointestinal disorders for celiac disease: a population based study. Clin Gastroenterol Hepatol 2015; S1542-3565: 00690-4.
 
[26]  Makharia GK, Verma AK, Amarchand R, Bhatnagar S, Das P, Goswami A, Bhatia V, Ahuja V, Datta Gupta S, Anand K. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011 May; 26(5):894-900.
 
[27]  Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001; 121: 1329-38.
 
[28]  De Marchi B, Astegiano M, Sapone N, Bresso F, Pagano N, Bertolusso L, Ponti V, Bruno M et al. Prevalence of coeliac disease in IBS patients in Turin [abstract]. Gastroenterology 2002; 122 (Suppl. 4): A193.
 
[29]  Funka K, Leja M, Bandere B, Gavars D. Low seroprevalence of celiac disease among patients with irritable bowel syndrome in Latvia [abstract]. Gut 2004; 53 (Suppl. VI):A198.
 
[30]  Sood, A., et al., Prevalence of celiac disease among school children in Punjab, North India. Journal of gastroenterology and hepatology, 2006. 21(10): p. 1622-1625.
 
[31]  Yachha, S.K., Celiac disease: India on the global map. Journal of gastroenterology and hepatology, 2006. 21(10): p. 1511-1513.
 
[32]  Kaur, G., et al., Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Human immunology, 2002. 63(8): p. 677-682.
 
[33]  Agrawal, S., et al., Association of human leucocyte‐DR and DQ antigens in coeliac disease: A family study. Journal of gastroenterology and hepatology, 2000. 15(7): p. 771-774.
 
[34]  Rani, R., M. Fernandez‐Viaea, and P. Stastny, Associations between HLA class II alleles in a North Indian population. Tissue Antigens, 1998. 52(1): p. 37-43.
 
[35]  Ravi kumar, M., et al., Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India. Tubercle and Lung Disease, 1999. 79(5): p. 309-317.
 
[36]  Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999; 94:888–894.
 
[37]  Sanchez-Vargas LA, Thomas-Dupont P, Torres-Aguilera M, Azamar-Jacome AA, et al. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study. Neurogastroenterol Motil. 2016 Feb 23.
 
[38]  Khaled Ali Jadallah, Yousef Saleh Khader. Celiac disease in patients with presumed irritable bowel syndrome: A case-finding study. World J Gastroenterol. 2009 November 14; 15(42): 5321-5325.
 
[39]  Patel P, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P, Ford AC. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol 2015; 50: 816-23.
 
[40]  Bakhshipour A, Nezam SK, Zakeri Z, Gharibi R, Bahari A, Kaykhaei MA. Coeliac disease in irritable bowel syndrome (Rome III) in Southeast Iran. Arab J Gastroenterol. 2012; 13: 24-27.
 
[41]  Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the “no man’s land” of gluten sensitivity. Am J Gastroenterol 2009; 104: 1587-94.
 
[42]  Aziz I, Lewis NR, Hadjivassiliou M, Winfield SN, Rugg N, Kelsall A, Newrick L, Sanders DS. A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care. Eur J Gastroenterol Hepatol 2014; 26: 33-39.